Global Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

According to APO Research, The global Blood Product market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blood Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Blood Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Blood Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Blood Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Blood Product include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Blood Product, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Blood Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Product revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Blood Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Blood Product revenue, projected growth trends, production technology, application and end-user industry.

Blood Product segment by Company

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Blood Product segment by Type

Albumin
Immunoglobulin
Clotting Factor
Others
Blood Product segment by Application

Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Blood Product segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Product industry.
Chapter 3: Detailed analysis of Blood Product companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Productrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Global Market Growth Prospects
1.5 Global Blood Product Growth Trends by Region
1.5.1 Global Blood Product Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Blood Product Market Size by Region (2019-2024)
1.5.3 Blood Product Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Blood Product Market Dynamics
2.1 Blood Product Industry Trends
2.2 Blood Product Industry Drivers
2.3 Blood Product Industry Opportunities and Challenges
2.4 Blood Product Industry Restraints
3 Competitive Landscape by Company
3.1 Global Blood Product Revenue by Company (2019-2024)
3.2 Global Blood Product Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Blood Product Key Company Head office and Area Served
3.4 Global Blood Product Company, Product Type & Application
3.5 Global Blood Product Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Blood Product Market CR5 and HHI
3.6.2 Global Top 5 and 10 Blood Product Players Market Share by Revenue in 2023
3.6.3 2023 Blood Product Tier 1, Tier 2, and Tier 3
4 Blood Product Market by Type
4.1 Global Blood Product Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Blood Product Market Size by Type (2019-2030)
4.3 Global Blood Product Market Size Share by Type (2019-2030)
5 Blood Product Market by Application
5.1 Global Blood Product Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Blood Product Market Size by Application (2019-2030)
5.3 Global Blood Product Market Size Share by Application (2019-2030)
6 Company Profiles
6.1 Takeda
6.1.1 Takeda Comapny Information
6.1.2 Takeda Business Overview
6.1.3 Takeda Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Takeda Blood Product Product Portfolio
6.1.5 Takeda Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 CSL Blood Product Product Portfolio
6.2.5 CSL Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Grifols Blood Product Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 Octapharma Blood Product Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Kedrion Blood Product Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 LFB Group
6.6.1 LFB Group Comapny Information
6.6.2 LFB Group Business Overview
6.6.3 LFB Group Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 LFB Group Blood Product Product Portfolio
6.6.5 LFB Group Recent Developments
6.7 Biotest
6.7.1 Biotest Comapny Information
6.7.2 Biotest Business Overview
6.7.3 Biotest Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Biotest Blood Product Product Portfolio
6.7.5 Biotest Recent Developments
6.8 BPL
6.8.1 BPL Comapny Information
6.8.2 BPL Business Overview
6.8.3 BPL Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 BPL Blood Product Product Portfolio
6.8.5 BPL Recent Developments
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Comapny Information
6.9.2 Shanghai RAAS Business Overview
6.9.3 Shanghai RAAS Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Shanghai RAAS Blood Product Product Portfolio
6.9.5 Shanghai RAAS Recent Developments
6.10 China Biologic Products
6.10.1 China Biologic Products Comapny Information
6.10.2 China Biologic Products Business Overview
6.10.3 China Biologic Products Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 China Biologic Products Blood Product Product Portfolio
6.10.5 China Biologic Products Recent Developments
6.11 Hualan Biological Engineering Inc.
6.11.1 Hualan Biological Engineering Inc. Comapny Information
6.11.2 Hualan Biological Engineering Inc. Business Overview
6.11.3 Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 Hualan Biological Engineering Inc. Blood Product Product Portfolio
6.11.5 Hualan Biological Engineering Inc. Recent Developments
6.12 Beijing Tiantan Biological Products Corp
6.12.1 Beijing Tiantan Biological Products Corp Comapny Information
6.12.2 Beijing Tiantan Biological Products Corp Business Overview
6.12.3 Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.12.4 Beijing Tiantan Biological Products Corp Blood Product Product Portfolio
6.12.5 Beijing Tiantan Biological Products Corp Recent Developments
6.13 Pacific Shuanglin
6.13.1 Pacific Shuanglin Comapny Information
6.13.2 Pacific Shuanglin Business Overview
6.13.3 Pacific Shuanglin Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.13.4 Pacific Shuanglin Blood Product Product Portfolio
6.13.5 Pacific Shuanglin Recent Developments
6.14 Boya Bio-Pharmaceutical
6.14.1 Boya Bio-Pharmaceutical Comapny Information
6.14.2 Boya Bio-Pharmaceutical Business Overview
6.14.3 Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.14.4 Boya Bio-Pharmaceutical Blood Product Product Portfolio
6.14.5 Boya Bio-Pharmaceutical Recent Developments
6.15 Paisi Feike Biology Pharmacy Co., Ltd.
6.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Comapny Information
6.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
6.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio
6.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
6.16 Xinjiang Deyuan Bioengineering
6.16.1 Xinjiang Deyuan Bioengineering Comapny Information
6.16.2 Xinjiang Deyuan Bioengineering Business Overview
6.16.3 Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.16.4 Xinjiang Deyuan Bioengineering Blood Product Product Portfolio
6.16.5 Xinjiang Deyuan Bioengineering Recent Developments
6.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
6.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Comapny Information
6.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
6.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio
6.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
6.18 Shenzhen Weiguang
6.18.1 Shenzhen Weiguang Comapny Information
6.18.2 Shenzhen Weiguang Business Overview
6.18.3 Shenzhen Weiguang Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.18.4 Shenzhen Weiguang Blood Product Product Portfolio
6.18.5 Shenzhen Weiguang Recent Developments
6.19 Shanxi Kangbao
6.19.1 Shanxi Kangbao Comapny Information
6.19.2 Shanxi Kangbao Business Overview
6.19.3 Shanxi Kangbao Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.19.4 Shanxi Kangbao Blood Product Product Portfolio
6.19.5 Shanxi Kangbao Recent Developments
6.20 Nanyue Biopharming Corporation Ltd
6.20.1 Nanyue Biopharming Corporation Ltd Comapny Information
6.20.2 Nanyue Biopharming Corporation Ltd Business Overview
6.20.3 Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (US$ Million) & (2019-2024)
6.20.4 Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio
6.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
7 North America
7.1 North America Blood Product Market Size (2019-2030)
7.2 North America Blood Product Market Size by Type
7.2.1 North America Blood Product Market Size by Type (2019-2024)
7.2.2 North America Blood Product Market Size by Type (2025-2030)
7.2.3 North America Blood Product Market Share by Type (2019-2030)
7.3 North America Blood Product Market Size by Application
7.3.1 North America Blood Product Market Size by Application (2019-2024)
7.3.2 North America Blood Product Market Size by Application (2025-2030)
7.3.3 North America Blood Product Market Share by Application (2019-2030)
7.4 North America Blood Product Market Size by Country
7.4.1 North America Blood Product Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Blood Product Market Size by Country (2019-2024)
7.4.3 North America Blood Product Market Size by Country (2025-2030)
7.4.4 North America Blood Product Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 Europe
8.1 Europe Blood Product Market Size (2019-2030)
8.2 Europe Blood Product Market Size by Type
8.2.1 Europe Blood Product Market Size by Type (2019-2024)
8.2.2 Europe Blood Product Market Size by Type (2025-2030)
8.2.3 Europe Blood Product Market Share by Type (2019-2030)
8.3 Europe Blood Product Market Size by Application
8.3.1 Europe Blood Product Market Size by Application (2019-2024)
8.3.2 Europe Blood Product Market Size by Application (2025-2030)
8.3.3 Europe Blood Product Market Share by Application (2019-2030)
8.4 Europe Blood Product Market Size by Country
8.4.1 Europe Blood Product Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Blood Product Market Size by Country (2019-2024)
8.4.3 Europe Blood Product Market Size by Country (2025-2030)
8.4.4 Europe Blood Product Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Blood Product Market Size (2019-2030)
9.2 China Blood Product Market Size by Type
9.2.1 China Blood Product Market Size by Type (2019-2024)
9.2.2 China Blood Product Market Size by Type (2025-2030)
9.2.3 China Blood Product Market Share by Type (2019-2030)
9.3 China Blood Product Market Size by Application
9.3.1 China Blood Product Market Size by Application (2019-2024)
9.3.2 China Blood Product Market Size by Application (2025-2030)
9.3.3 China Blood Product Market Share by Application (2019-2030)
10 Asia
10.1 Asia Blood Product Market Size (2019-2030)
10.2 Asia Blood Product Market Size by Type
10.2.1 Asia Blood Product Market Size by Type (2019-2024)
10.2.2 Asia Blood Product Market Size by Type (2025-2030)
10.2.3 Asia Blood Product Market Share by Type (2019-2030)
10.3 Asia Blood Product Market Size by Application
10.3.1 Asia Blood Product Market Size by Application (2019-2024)
10.3.2 Asia Blood Product Market Size by Application (2025-2030)
10.3.3 Asia Blood Product Market Share by Application (2019-2030)
10.4 Asia Blood Product Market Size by Country
10.4.1 Asia Blood Product Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Blood Product Market Size by Country (2019-2024)
10.4.3 Asia Blood Product Market Size by Country (2025-2030)
10.4.4 Asia Blood Product Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Blood Product Market Size (2019-2030)
11.2 MEALA Blood Product Market Size by Type
11.2.1 MEALA Blood Product Market Size by Type (2019-2024)
11.2.2 MEALA Blood Product Market Size by Type (2025-2030)
11.2.3 MEALA Blood Product Market Share by Type (2019-2030)
11.3 MEALA Blood Product Market Size by Application
11.3.1 MEALA Blood Product Market Size by Application (2019-2024)
11.3.2 MEALA Blood Product Market Size by Application (2025-2030)
11.3.3 MEALA Blood Product Market Share by Application (2019-2030)
11.4 MEALA Blood Product Market Size by Country
11.4.1 MEALA Blood Product Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Blood Product Market Size by Country (2019-2024)
11.4.3 MEALA Blood Product Market Size by Country (2025-2030)
11.4.4 MEALA Blood Product Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings